Belatacept and the Risk of Cytomegalovirus, BK Polyomavirus, and Epstein-Barr Virus Post-transplant Lymphoproliferative Disease After Kidney Transplantation: A Meta-Analysis and Systematic Review. (PubMed, J Transplant) - Sep 14, 2026 - "The risk of CMV and BK polyomavirus infections may also be increased with real-world belatacept use. However, these observations should be interpreted with consideration for the inherent limitations of NRTs."
Journal • Retrospective data • Review • Cytomegalovirus Infection • Epstein-Barr Virus Infections • Infectious Disease • Transplantation
|
|
Cybele Lara R Abad; Raymund R Razonable
|